Home urine testing for lupus patients
Part of Immune system & allergy, Skin clinical trials.
This study tests whether lupus patients can use a home urine test to monitor their kidney health, which could help catch kidney problems early. It is for patients who have lupus and may have had kidney involvement before, or are at risk of developing it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a lupus diagnosis based on standard criteria (ACR, SLICC, or ACR/EULAR).
- If you've had kidney disease related to lupus, it is currently under control (urine protein-to-creatinine ratio less than 0.3).
- If you've never had kidney disease, you were diagnosed with lupus within the last 5 years, have certain antibodies (anti-dsDNA) or low complement levels (C3/C4), and your current urine protein is also less than 0.3.
- You have a mobile phone (any type).
- You are already enrolled in the SAMPLE Biorepository (s14-00487).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This trial tests a new treatment, UB-VV410, for people with active systemic lupus erythematosus (SLE) or lupus nephritis (kidney inflammation caused by lupus) that hasn't responded to standard treatments. It aims to see if this therapy can help control the disease.
This study looks at tiny particles in urine to better understand and monitor lupus-related kidney problems. It may help find better ways to track the disease without invasive biopsies.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.